CASI Pharmaceuticals Inc

NAS:CASI (USA)  
$ 5.56 -0.04 (-0.71%) 01:29 PM EST
At Loss
P/B:
2.59
Market Cap:
$ 74.60M
Enterprise V:
$ 24.61M
Volume:
7.99K
Avg Vol (2M):
37.73K
Also Trade In:
Volume:
7.99K
At Loss
Avg Vol (2M):
37.73K

Business Description

Description
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world.
Name Current Vs Industry Vs History
Cash-To-Debt 26.49
Equity-to-Asset 0.39
Debt-to-Equity 0.05
Debt-to-EBITDA -0.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.81
Distress
Grey
Safe
Beneish M-Score -4.61
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 16.08
9-Day RSI 34.05
14-Day RSI 41.48
6-1 Month Momentum % 105.6
12-1 Month Momentum % 148.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.91
Quick Ratio 4.17
Cash Ratio 3.01
Days Inventory 177.07
Days Sales Outstanding 105.06
Days Payable 67.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.2
Shareholder Yield % 2.05

Financials (Next Earnings Date:2024-04-26 Est.)

CASI's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CASI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

CASI Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 42.264
EPS (TTM) ($) -3.01
Beta 0.8
Volatility % 72.86
14-Day RSI 41.48
14-Day ATR ($) 0.568764
20-Day SMA ($) 6.3185
12-1 Month Momentum % 148.44
52-Week Range ($) 1.6008 - 8.48
Shares Outstanding (Mil) 13.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CASI Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

CASI Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

CASI Pharmaceuticals Inc Frequently Asked Questions

What is CASI Pharmaceuticals Inc(CASI)'s stock price today?
The current price of CASI is $5.56. The 52 week high of CASI is $8.48 and 52 week low is $1.60.
When is next earnings date of CASI Pharmaceuticals Inc(CASI)?
The next earnings date of CASI Pharmaceuticals Inc(CASI) is 2024-04-26 Est..
Does CASI Pharmaceuticals Inc(CASI) pay dividends? If so, how much?
CASI Pharmaceuticals Inc(CASI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1